Furthermore, treatment of N2a cells with statins, which impair cholesterol biosynthesis and are widely used in the treatment of hyperlipidemia, resulted in phosphorylation of EGFR and downstream kinases such as PI3K and Akt55. Here, EGFR is linked to hyperlipidemia.